ARAVIVE (ARAV)
(Delayed Data from NSDQ)
$0.04 USD
0.00 (0.00%)
Updated Jan 26, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
ARAVIVE, INC [ARAV]
Reports for Purchase
Showing records 81 - 100 ( 104 total )
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Expecting Further Visibility Boost for AVB-500 in 2020
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
AVB-500 Expansion Beyond Oncology Begins as Expected; Target Lowered to $25
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
AVB-500 Ovarian Update Exceeds Expectations With Dose-Exposure Results; Target Upped to $31
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
New IST Could Contribute to AVB-500''s Success in Ovarian Cancer
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
3Q19 Results; AVB-500 Builds Confidence and Prepares for Expansion Beyond Ovarian Cancer
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Target Acquired With Early and Impressive Clinical Validation; Initiating at Buy and $18 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Biotechnology - ESMO 2019 Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
EMSO 2019 Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
2019 PacGrow Healthcare Conference: Day 1 Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Biotechnology - ASCO Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: ARAVIVE, INC
Industry: Medical - Generic Drugs
Biotechnology- ASCO Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.